Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Kura Oncology
Over the past year LXRX returned +11.3% and KURA returned −23.6%; their daily moves had a correlation of 0.30.
LXRX +11.3% KURA −23.6%Growth of $1, one year, split-adjusted
| Metric | LXRX | KURA |
|---|---|---|
| Price | $1.48 | $7.61 |
| Market cap | $658.5M | $677.0M |
| Today | +1.37% | −22.98% |
| 1 month | −15.4% | −27.7% |
| 6 months | −7.5% | −20.4% |
| Year to date | +28.7% | −26.8% |
| 1 year | +8.8% | −22.1% |
| Revenue growth (YoY) | −97.6% | +36.5% |
| Gross margin | 94.4% | 98.8% |
| Net margin | −4591.8% | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | 15.9× | 8.8× |
| Net cash | $139.2M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 51.9% | 76.9% |
| Short % of float | 11.8% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).